Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Alector, Inc. (ALEC) Market Cap & Valuation Ratios

Alector, Inc. (ALEC) has a market cap of $204.3M and a price-to-sales ratio of 14.7, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALECAlector, Inc.Follow ALEC — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
204.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
ALEC0.2—3.0——-83%——
VNDA0.2—0.9——+6%-86%-65%
DRUG0.2————+4943%——
PALI0.2———————
LXEO0.2——————-78%
KROS0.2————-94%—-956%
IKT0.2——————-54%
NAGE0.213.51.011.33.0%+11%8%102%
ADCT0.2—1.0——+3%-125%—
KRRO0.2—25.8——-62%—-138%
TRDA0.2—15.5——-94%—-80%
Median of these 1013.51.011.33.0%+3%-86%-78%

; EV/Sales 3.0 vs. 1.0.

Growth vs. price

each dot a company · hover or tap for values

Alector, Inc. — questions

What is Alector, Inc.'s market cap?
$204.3M.
What is Alector, Inc.'s price-to-sales ratio?
14.7.

Every figure on this page comes from Alector, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.